ATE182586T1 - Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung - Google Patents

Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Info

Publication number
ATE182586T1
ATE182586T1 AT94102183T AT94102183T ATE182586T1 AT E182586 T1 ATE182586 T1 AT E182586T1 AT 94102183 T AT94102183 T AT 94102183T AT 94102183 T AT94102183 T AT 94102183T AT E182586 T1 ATE182586 T1 AT E182586T1
Authority
AT
Austria
Prior art keywords
aminophthhaloylhydrazide
composition
application
pharmacological use
pertains
Prior art date
Application number
AT94102183T
Other languages
English (en)
Inventor
Lonid Minin
Slava Saizev
Original Assignee
Medinkor Zmm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinkor Zmm Ag filed Critical Medinkor Zmm Ag
Application granted granted Critical
Publication of ATE182586T1 publication Critical patent/ATE182586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94102183T 1993-02-19 1994-02-12 Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung ATE182586T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530/93A CH683965A5 (it) 1993-02-19 1993-02-19 Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.

Publications (1)

Publication Number Publication Date
ATE182586T1 true ATE182586T1 (de) 1999-08-15

Family

ID=4189123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102183T ATE182586T1 (de) 1993-02-19 1994-02-12 Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Country Status (6)

Country Link
US (1) US5543410A (de)
EP (1) EP0617024B1 (de)
JP (1) JP2693373B2 (de)
AT (1) ATE182586T1 (de)
CH (1) CH683965A5 (de)
DE (1) DE69419640D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1203587B1 (de) 2000-03-28 2010-07-14 Abidov, Musea Tazhudinovich Arzneimittel und dessen herstellungsprozess
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
US6953799B1 (en) * 2002-10-30 2005-10-11 Bach Pharma, Inc. Modulation of cell fates and activities by diketo phthalazines
US8592421B2 (en) 2003-08-04 2013-11-26 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
RS52999B (en) * 2004-06-23 2014-02-28 Synta Pharmaceuticals Corp. BIS (AMIDIDA TIO-HYDRAZIDE) Salts for Cancer Treatment
US20100222584A1 (en) * 2009-02-06 2010-09-02 Bach Pharma, Inc. Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
US8895555B2 (en) 2009-02-19 2014-11-25 Bach Pharma, Inc. Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS
AT509045B1 (de) * 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
CA2791327C (en) 2010-03-01 2018-10-30 Metriopharm Ag Crystalline forms of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same, method for production of said forms and use of said forms for modulating the immune system
EP2688565A1 (de) 2011-03-23 2014-01-29 Semorex Technologies Ltd. Behandlung proliferativer erkrankungen mit einem chemilumineszenzmittel
RU2577849C2 (ru) * 2013-09-25 2016-03-20 Общество с ограниченной ответственностью "Сэлвим" Бис(5-амино-1,4-диоксо-1,2,3,4-тетрагидрофталазин-2-ил)цинк, способ его получения, фармацевтическая композиция на его основе, лечебные средства на его основе, способ лечения кожных заболеваний и способ лечения гастрита
ES2753577T3 (es) 2014-12-18 2020-04-13 Metriopharm Ag Forma cristalina de 5-amino-2,3-dihidroftalazina-1,4-diona sal sódica, los preparados farmacéuticos que la contengan y método de producción
EP3248602A1 (de) * 2016-05-26 2017-11-29 MetrioPharm AG Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion bei der behandlung von entzündlichen und/oder degenerativen erkrankungen der sehnen, gelenkbänder, gelenkkapseln und schleimbeutel
EP3858358A1 (de) * 2020-01-31 2021-08-04 MetrioPharm AG Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion zur behandlung von seltenen chronischen entzündlichen lungenerkrankungen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2453578A (en) * 1944-02-19 1948-11-09 American Cyanamid Co Preparation of chemiluminescent composition of matter
GB1100911A (en) * 1963-08-20 1968-01-24 Benger Lab Ltd Phthalazine derivatives
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
JPS5116430B2 (de) * 1971-08-05 1976-05-24
JPS5023689B2 (de) * 1971-11-29 1975-08-09
US3957776A (en) * 1973-02-28 1976-05-18 Delmar Chemicals Limited Novel phthalazinone compounds
US4011219A (en) * 1975-03-28 1977-03-08 Chugai Seiyaku Kabushiki Kaisha Phthalazine derivatives and salts thereof
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4334069A (en) * 1978-07-24 1982-06-08 Miles Laboratories, Inc. Chemiluminescent phthalhydrazide-labeled hapten conjugates
US4226993A (en) * 1978-07-24 1980-10-07 Miles Laboratories, Inc. Amino-functionalized phthalhydrazides
US4355165A (en) * 1978-07-24 1982-10-19 Miles Laboratories, Inc. Amino-functionalized phthalhydrazide intermediates
US4250180A (en) * 1979-07-16 1981-02-10 Ortho Pharmaceutical Corporation Method of treating arrhythmia
EP0046742B1 (de) * 1980-08-25 1984-06-27 KabiVitrum AB Peptidsubstrate zum Bestimmen der Proteaseaktivität
HU181184B (en) * 1980-09-12 1983-06-28 Eszakmagyar Vegyimuevek Composition for replacing kinetine,the effect and membraneactivity of which is similar to citokinine,which composition improves plant productivity,quantity of protein-nitrogen and anion-absorptivity
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
US4665181A (en) * 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
CH683966A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.

Also Published As

Publication number Publication date
EP0617024A1 (de) 1994-09-28
JP2693373B2 (ja) 1997-12-24
JPH07179431A (ja) 1995-07-18
CH683965A5 (it) 1994-06-30
EP0617024B1 (de) 1999-07-28
DE69419640D1 (de) 1999-09-02
US5543410A (en) 1996-08-06

Similar Documents

Publication Publication Date Title
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
FI954718A (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
SE9604786D0 (sv) New compounds
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE69419640D1 (de) Pharmakologische Verwendung von 5-Aminophthaloylhydrazide; ihre Zusammensetzung und Anwendung
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
DE69623899T2 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
ATE304543T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
DE69106630D1 (de) Wässerige kosmetische Zusammensetzung und dessen Herstellungsverfahren.
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
DE69624707T2 (de) Therapeutische verwendung von 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonsäure und ihre salze
ATE229034T1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
DE69414194T2 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
DE69327813D1 (de) Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung
FI961977A (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
NO944809L (no) Biologisk aktive ureidoderivater som er nyttig i behandling av lentivirus-indusert sykdom
AR021502A1 (es) Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso
NO994339D0 (no) Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat